As the Australian market faces a slightly lower opening amid global tech sector challenges, investors are increasingly cautious, influenced by Wall Street's recent downturn and upcoming central bank meetings. In this climate, growth companies with high insider ownership can be particularly appealing as they often signal strong internal confidence and alignment with shareholder interests.

Top 10 Growth Companies With High Insider Ownership In Australia

Name Insider Ownership Earnings Growth Wisr (ASX:WZR) 10.2% 94.7% Titomic (ASX:TTT) 14.8% 74.9% Sea Forest (ASX:SEA) 15.1% 92.5% Pointerra (ASX:3DP) 20.4% 110.3% Newfield Resources (ASX:NWF) 31.5% 72.1% Lunnon Metals (ASX:LM8) 11% 31.4% Elsight (ASX:ELS) 17.3% 89.4% Echo IQ (ASX:EIQ) 18.9% 51.5% Adveritas (ASX:AV1) 18% 96.8% Advanced Energy Minerals (ASX:AEM) 37.5% 64.1%

Click here to see the full list of 105 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.

Underneath we present a selection of stocks filtered out by our screen.

Catapult Sports

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Catapult Sports Ltd is a sports science and analytics company that develops and supplies technologies to enhance athlete and team performance across multiple regions, with a market cap of A$1.04 billion.

Operations: The company's revenue is primarily derived from three segments: Performance & Health ($69.95 million), Tactics & Coaching ($37.56 million), and Media & Other ($18.81 million).

Insider Ownership: 14.0%

Earnings Growth Forecast: 41.3% p.a.

Catapult Sports is poised for growth with earnings expected to rise 41.3% annually, and revenue projected to grow at 15.5% per year, outpacing the Australian market. Despite a current net loss of US$8.62 million, profitability is anticipated within three years. Analysts predict a significant stock price increase of 93.5%. Recent product advancements like Perch P2 enhance its athlete performance offerings, potentially expanding its market presence and value proposition in sports training and rehabilitation sectors.

Get an in-depth perspective on Catapult Sports' performance by reading our analyst estimates report here. The valuation report we've compiled suggests that Catapult Sports' current price could be inflated.ASX:CAT Earnings and Revenue Growth as at Feb 2026

Emerald Resources

Simply Wall St Growth Rating: ★★★★★★

Overview: Emerald Resources NL is involved in the exploration and development of mineral reserves in Cambodia and Australia, with a market cap of A$4.35 billion.

Operations: The company's revenue is primarily derived from mine operations, amounting to A$430.41 million.

Story Continues

Insider Ownership: 18.4%

Earnings Growth Forecast: 46.6% p.a.

Emerald Resources is set for substantial growth, with earnings projected to increase by 46.6% annually, outperforming the Australian market. Revenue is also expected to grow significantly at 39.7% per year. The company's Okvau Gold Mine recently produced 25,030 ounces of gold in the December quarter, selling at an average price of US$4,118/oz. Despite trading well below its estimated fair value and no recent insider trading activity, it remains a strong growth prospect with high forecasted returns on equity.

Click to explore a detailed breakdown of our findings in Emerald Resources' earnings growth report. According our valuation report, there's an indication that Emerald Resources' share price might be on the expensive side.ASX:EMR Earnings and Revenue Growth as at Feb 2026

Mesoblast

Simply Wall St Growth Rating: ★★★★★★

Overview: Mesoblast Limited, along with its subsidiaries, focuses on developing regenerative medicine products across Australia, the United States, Singapore, and Switzerland with a market cap of A$3.08 billion.

Operations: The company's revenue segment is derived from the development of its cell technology platform for commercialization, amounting to $17.20 million.

Insider Ownership: 32.7%

Earnings Growth Forecast: 55.6% p.a.

Mesoblast's growth potential is underscored by its strategic focus on cell therapies, with Ryoncil showing promising real-world outcomes in treating pediatric SR-aGvHD and expanding to adult markets. The company's revenue is forecast to grow at 42.7% annually, significantly outpacing the Australian market. While insider trading has been minimal recently, Mesoblast trades substantially below fair value estimates and aims for profitability within three years. Recent FDA feedback supports its pipeline's efficacy, enhancing future growth prospects.

Click here and access our complete growth analysis report to understand the dynamics of Mesoblast. Upon reviewing our latest valuation report, Mesoblast's share price might be too pessimistic.ASX:MSB Earnings and Revenue Growth as at Feb 2026

Key Takeaways

Discover the full array of 105 Fast Growing ASX Companies With High Insider Ownership right here. Ready To Venture Into Other Investment Styles? The end of cancer? These 29 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include ASX:CAT ASX:EMR and ASX:MSB.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments